Decision aids for thrombolytic therapy in acute ischemic stroke: a scoping review
5 affiliations
- 1Critical Care Medicine Ward 3, The Second Hospital of Lanzhou University
- 2School of Nursing, Lanzhou University
- 3Hematology Department 1 Ward, The Second Hospital of Lanzhou University
- 4Department of Cardiovascular Medicine, the Second Hospital of Lanzhou University
- 5Department of Nursing, The Second Hospital of Lanzhou University
Abstract
Objective: This scoping review aims to summarize existing decision aids (DAs) for thrombolytic therapy in patients with acute ischemic stroke (AIS) and/or their surrogate decision-makers, explore their formats and effects, and provide implications for future tool development.
Methods: Systematic literature searches were conducted in PubMed, Cochrane Library, Embase, Web of Science, CNKI and SinoMed using combined subject terms and free words. Studies focusing on the development of DAs for thrombolytic therapy in patients with AIS and/or their surrogate decision-makers were included. The retrieval period spanned from database establishment to March 15, 2026.
Results: A total of 9 DAs were identified and classified into standardized DAs and personalized DAs, covering animated video-based aids, visual aids, conversation guide manual and computer-based programs. Evaluation based on the International Patient Decision Aid Standards (IPDASi) indicated that only a few DAs partially met the certification criteria. Most of them focus on the delivery of risk–benefit information, with deficiencies in value clarification, psychological support and long-term outcome follow-up.
Conclusion: 9 DAs for AIS thrombolysis were identified, comprising standardized DAs and personalized DAs. Most focus on information delivery, with insufficient attention to value clarification, psychological support, and long-term outcome assessment. Their independent efficacy remains unverified, as existing evidence derives mainly from single-center pre-post studies confounded by concurrent workflow changes. Future DAs should shift from information provision toward decision empowerment, with multicenter randomized controlled trials warranted to confirm clinical effectiveness.
Related
- Assessment of intravenous thrombolytic therapy response in acute ischemic stroke using NIHSS changes and laboratory parameters
- Ischemic Stroke During Rivaroxaban Therapy: The Importance of Food-Dependent Absorption and Careful Assessment Before Antithrombotic Escalation
- Programmed oscillatory oxygen therapy: Reframing oxygen as a dynamic signal for restoring cerebrovascular regulation after ischemic stroke
- Decision dilemmas and insights in secondary prevention of ischemic stroke: a case report of an elderly patient with hereditary thrombophilia and high-risk patent foramen ovale
- Physician Decision-Making in Acute Ischemic Stroke with and without a Guideline-Encoded Clinical Decision Support System
BibTeX
@article{lingling2026decision,
title = {{Decision aids for thrombolytic therapy in acute ischemic stroke: a scoping review}},
author = {Li Lingling and Zang Ruijin and Wang Lili and Yadong Wang and Wang Lele and Zhao Zerun and Cai Minmin and Wang Xinglei and Dou Xinman},
journal = {Frontiers in Neurology},
year = {2026},
month = nov,
doi = {10.3389/fneur.2026.1896108},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1896108/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Decision aids for thrombolytic therapy in acute ischemic stroke: a scoping review
AU - Li Lingling
AU - Zang Ruijin
AU - Wang Lili
AU - Yadong Wang
AU - Wang Lele
AU - Zhao Zerun
AU - Cai Minmin
AU - Wang Xinglei
AU - Dou Xinman
PY - 2026
DA - 2026/11/05
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1896108
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1896108/full
AB - Objective: This scoping review aims to summarize existing decision aids (DAs) for thrombolytic therapy in patients with acute ischemic stroke (AIS) and/or their surrogate decision-makers, explore their formats and effects, and provide implications for future tool development. Methods: Systematic literature searches were conducted in PubMed, Cochrane Library, Embase, Web of Science, CNKI and SinoMed using combined subject terms and free words. Studies focusing on the development of DAs for thrombolytic therapy in patients with AIS and/or their surrogate decision-makers were included. The retrieval period spanned from database establishment to March 15, 2026. Results: A total of 9 DAs were identified and classified into standardized DAs and personalized DAs, covering animated video-based aids, visual aids, conversation guide manual and computer-based programs. Evaluation based on the International Patient Decision Aid Standards (IPDASi) indicated that only a few DAs partially met the certification criteria. Most of them focus on the delivery of risk–benefit information, with deficiencies in value clarification, psychological support and long-term outcome follow-up. Conclusion: 9 DAs for AIS thrombolysis were identified, comprising standardized DAs and personalized DAs. Most focus on information delivery, with insufficient attention to value clarification, psychological support, and long-term outcome assessment. Their independent efficacy remains unverified, as existing evidence derives mainly from single-center pre-post studies confounded by concurrent workflow changes. Future DAs should shift from information provision toward decision empowerment, with multicenter randomized controlled trials warranted to confirm clinical effectiveness.
SN - 1664-2295
ER -